4-oxo-N-(4-hydroxyphenyl)retinamide: Two Independent Ways to Kill Cancer Cells

Autor Tiberio, Paola, Cavadini, Elena, Abolafio, Gabriella, Formelli, Franca, Appierto, Valentina
Vydáno 2010

AF1q: A Novel Mediator of Basal and 4-HPR-Induced Apoptosis in Ovarian Cancer Cells

Autor Tiberio, Paola, Cavadini, Elena, Callari, Maurizio, Daidone, Maria Grazia, Appierto, Valentina
Vydáno 2012

Challenges in Using Circulating miRNAs as Cancer Biomarkers

Autor Tiberio, Paola, Callari, Maurizio, Angeloni, Valentina, Daidone, Maria Grazia, Appierto, Valentina
Vydáno v Biomed Res Int (2015)

Sodium 4-Carboxymethoxyimino-(4-HPR) a Novel Water-Soluble Derivative of 4-Oxo-4-HPR Endowed with In Vivo Anticancer Activity on Solid Tumors

Autor Tiberio, Paola, Cavadini, Elena, Cleris, Loredana, Dallavalle, Sabrina, Musso, Loana, Daidone, Maria G., Appierto, Valentina
Vydáno v Front Pharmacol (2017)

Proposal of supervised data analysis strategy of plasma miRNAs from hybridisation array data with an application to assess hemolysis-related deregulation

Autor Landoni, Elena, Miceli, Rosalba, Callari, Maurizio, Tiberio, Paola, Appierto, Valentina, Angeloni, Valentina, Mariani, Luigi, Daidone, Maria Grazia
Vydáno v BMC Bioinformatics (2015)

Involvement of AF1q/MLLT11 in the progression of ovarian cancer

Autor Tiberio, Paola, Lozneanu, Ludmila, Angeloni, Valentina, Cavadini, Elena, Pinciroli, Patrizia, Callari, Maurizio, Carcangiu, Maria Luisa, Lorusso, Domenica, Raspagliesi, Francesco, Pala, Valentina, Daidone, Maria Grazia, Appierto, Valentina
Vydáno v Oncotarget (2017)